GENEREX BIOTECH CORP (OTC:GNBT)
Industry: Healthcare

Listed 4 Consecutive Market Days. On List as of 02/15/2012 Through 02/22/2012

Generex Biotechnology Corporation, through its subsidiary, Hema Diagnostic Systems, LLC, focuses on the development, manufacture, and distribution of in-vitro medical diagnostics for infectious diseases in Canada and the United States. The company offers Rapid Diagnostic Tests for human immunodeficiency virus?½ w/p24Ab, tuberculosis-XT, malaria, hepatitis, syphilis, typhoid, dengue, and other infectious diseases. Generex Biotechnology Corporation was founded in 1983 and is based in Miramar, Florida.

Current Quote*
Last: $3.000
Change: 0.000
Book: $Unk
Volume: 740

As Of: 04/23 16:40 ET
*Quotes delayed by 20min.

BuyIns.Net Alerts for Symbol GNBT

  • No BuyIns.Net Alerts Available for GNBT

Graphs for GNBT


3 Month Graph


6 Month Graph


1 Year Graph